Current opinion in oncologyHumansLymphomaLarge B-CellDiffuseImmunotherapy
Predictors of response to CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a consolidated review.
Ori Ben Valid, Roni Shouval
Published: 202510.1097/CCO.0000000000001188
Abstract
PURPOSE OF REVIEW: CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy has transformed outcomes for relapsed/refractory large B-cell lymphoma (LBCL), yet nearly half of treated patients relapse, and toxicities remain frequent. A deeper und…
Preview only. Read the full abstract at the source